Page 181 - Color Atlas of Biochemistry
P. 181
172 Metabolism
Biosynthesis of cholesterol (effectors: hormones). Insulin and thyroxine
stimulate the enzyme and glucagon inhibits it
Cholesterol is a major constituent of the cell by cAMP-dependent phosphorylation. A large
membranes of animal cells (see p. 216). It supply of cholesterol from food also inhibits
wouldbepossiblefor thebodyto provide its 3-HMG-CoA reductase.
full daily cholesterol requirement (ca. 1 g) by (2) Formation of isopentenyl diphosphate.
synthesizing it itself. However, with a mixed After phosphorylation, mevalonate is decar-
diet, only about half of the cholesterol is de- boxylated to isopentenyl diphosphate, with
rived from endogenous biosynthesis,which consumption of ATP. Thisisthe component
takes place in the intestine and skin, and from which all of the isoprenoids are built
mainly in the liver (about 50%). The rest is (see p. 53).
taken up from food. Most of the cholesterol (3) Formation of squalene. Isopentenyl
is incorporated into the lipid layer of plasma diphosphate undergoes isomerization to
membranes, or converted into bile acids (see form dimethylallyl diphosphate. The two C 5
p. 314). A very small amount of cholesterol is molecules condense to yield geranyl diphos-
used for biosynthesis of the steroid hormones phate, and the addition of another isopen-
(see p. 376). In addition, up to 1 g cholesterol tenyl diphosphate produces farnesyl diphos-
per day is released into the bile and thus phate. This can then undergo dimerization, in
excreted. a head-to-head reaction, to yield squalene.
Farnesyl diphosphate is also the starting-
point for other polyisoprenoids, such as doli-
A. Cholesterol biosynthesis
chol (see p. 230) and ubiquinone (see p. 52).
Cholesterol is one of the isoprenoids, synthe- (4) Formation of cholesterol. Squalene, a
sis of which starts from acetyl CoA (see p. 52). linear isoprenoid, is cyclized, with O 2 being
In a long and complex reaction chain, the C 27 consumed, to form lanosterol, a C 30 sterol.
sterol is built up from C 2 components. The Three methyl groups are cleaved from this
biosynthesis of cholesterol can be divided in the subsequent reaction steps, to yield the
into four sections. In the first (1), end product cholesterol. Some of these reac-
mevalonate, aC 6 compound, arises from tions are catalyzed by cytochrome P450 sys-
three molecules of acetyl CoA. In the second tems (see p. 318).
part (2), mevalonate is converted into isopen- The endergonic biosynthetic pathway de-
tenyl diphosphate, the “active isoprene.” In scribed above is located entirely in the smooth
the third part (3), six of these C 5 molecules endoplasmic reticulum. The energy needed
are linked to produce squalene, aC 30 com- comes from the CoA derivatives used and
pound. Finally, squalene undergoes cycliza- from ATP. The reducing agent in the formation
tion, with three C atoms being removed, to of mevalonate and squalene, as well as in the
yield cholesterol (4). The illustration only final steps of cholesterol biosynthesis, is
+
shows the most important intermediates in NADPH+H .
biosynthesis. The division of the intermediates of the
(1) Formation of mevalonate. The conver- reaction pathway into three groups is charac-
sion of acetyl CoA to acetoacetyl CoA and then teristic: CoA compounds, diphosphates, and
to 3-hydroxy-3-methylglutaryl CoA (3-HMG highly lipophilic, poorly soluble compounds
CoA) corresponds to the biosynthetic path- (squalene to cholesterol), which are bound to
way for ketone bodies (details on p. 312). In sterol carriers in the cell.
this case, however, the synthesis occurs not in
the mitochondria as in ketone body synthesis,
but in the smooth endoplasmic reticulum. In
the next step, the 3-HMG group is cleaved
from the CoA and at the same time reduced
+
to mevalonate with the help of NADPH+H . 3-
HMG CoA reductase is the key enzyme in cho-
lesterol biosynthesis. It is regulated by repres-
sion of transcription (effectors: oxysterols
such as cholesterol) and by interconversion
Koolman, Color Atlas of Biochemistry, 2nd edition © 2005 Thieme
All rights reserved. Usage subject to terms and conditions of license.